AstraZeneca Pharma India Ltd. — Board/Management Information 2024

Mar 25, 2024

==> picture [478 x 66] intentionally omitted <==

March 25, 2024

The Manager- Listing BSE Limited

Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort Mumbai – 400 001

The Manager- Listing

National Stock Exchange of India Limited

Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E) Mumbai – 400 051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015 Appointment of Senior Management Personnel

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Mr. Vinay Sharma as Business Unit Head - Rare Disease unit with effect from July 1, 2024.

In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A .

Kindly take the above information on record.

For AstraZeneca Pharma India Limited

MANAS Digitally signed by MANASA RAMA A RAMA Date: 2024.03.25 10:10:01 +05'30' Manasa. R Company Secretary

==> picture [452 x 59] intentionally omitted <==

==> picture [478 x 66] intentionally omitted <==

Annexure - A

Sl.	Particulars	Details
No
1	Reasonforchangeviz.appointment,resignation,removal, death or otherwise;	Appointment of Mr. Vinay Sharma as Business Unit Head -Rare Disease Business Unit
2	Date of appointment/ cessation(as applicable) and term ofappointment	Effective July 1, 2024Term of appointment – Full – time employement
3	Brief Profile	Mr. Vinay Sharma is a Post‐Graduate in MarketingManagement and Business Administration with over 23 years ofrich industry experience. He joined AstraZeneca India in 2013as Marketing Manager Diabetes. Over the last decade, years, hehas held multiple sales, marketing, patient advocacy lead andleadershippositionsinAstraZenecaIndiaandotherinternational markets. He has been instrumental in leading thebest-in-class launch of Forxiga in India.Currently, Mr. Vinay Sharma is a part of the Philippines CountryLeadership Team as Business Unit Head Respiratory &Immunology.
4	Disclosureofrelationshipsbetween directors	Not Applicable

==> picture [452 x 59] intentionally omitted <==